Sharpless: ‘There Will Be No Pause’ On Existing FDA Initiatives

By David Roza / May 2, 2019 at 6:10 PM
Speaking before a room full of lawyers representing FDA-regulated industries of all stripes, FDA Acting Commissioner Ned Sharpless reiterated that under his leadership the agency will stay the course on the wide range of initiatives that have been advanced under previous commissioners such as Scott Gottlieb, whose tenure marked new regulatory paradigm shifts in nearly every sector under agency oversight. “There will be no pause at the FDA,” Sharpless said at the start of the Food and Drug Law Institute’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.